Qualio
Qualio is a purpose-built quality and compliance platform for life sciences companies operating in complex, high-stakes regulatory environments. Medical device, SaMD, biotech, and pharma teams use Qualio to replace fragmented eQMS tools, spreadsheets, and consultant-driven audits with a single, validated system that delivers continuous audit and inspection readiness.
Qualio combines a modern eQMS with Compliance Intelligence—an AI-driven layer that continuously evaluates how well real operating data aligns with regulatory requirements. Instead of treating audits as one-off events, teams gain always-on visibility into compliance coverage, risk exposure, and readiness across FDA, ISO, EU MDR, GxP, and software-intensive standards.
Core quality workflows—document control, training, CAPA, change management, supplier quality, and design controls—are directly connected to regulatory obligations and objective evidence. Deep integrations with Jira, Azure DevOps, GitHub, TestRail, and Salesforce automatically capture proof from development and operational systems, eliminating manual evidence gathering and reducing compliance drag on engineering teams.
Compliance Intelligence runs multi-standard gap analysis in under an hour, flags emerging risks before they become findings or 483s, and maps reusable evidence across frameworks to accelerate submissions and market expansion. All insights are explainable and traceable back to specific clauses and internal policies, supporting validation and audit expectations.
The result: audit readiness in weeks instead of months, fewer fire drills, faster launches, and lower long-term compliance cost. Qualio turns compliance from a reactive burden into a predictable, scalable system.
Learn more
CoVigilAI
CoVigilAI is a cutting-edge solution for monitoring medical literature that leverages artificial intelligence and sophisticated data analysis to identify and manage adverse drug reactions proactively, thereby safeguarding patient well-being and adhering to regulatory standards in real time. This platform simplifies the tracking of scientific and medical literature by sourcing information from major global databases like PubMed and Embase, offering customizable search parameters that enhance the pharmacovigilance literature review process. Additionally, it systematically reviews scientific articles and publications from various local journals, ensuring comprehensive global and localized literature oversight. Utilizing advanced algorithms, the system classifies Individual Case Safety Reports (ICSRs) into three categories: valid, potential, and invalid cases, while its automated key entity recognition capability adeptly identifies essential elements such as patients, medications, adverse reactions, and relevant medical events. This holistic approach not only streamlines the monitoring process but also significantly enhances the accuracy and efficiency of drug safety assessments.
Learn more
DF Literature Monitor
DF Literature Monitor is a cutting-edge AI-driven tool that streamlines the process of monitoring extensive literature and enhances safety oversight procedures. It connects with key local and global literature sources to retrieve articles simultaneously, utilizing semantic search technology to efficiently pinpoint pertinent research. The system includes features such as automatic de-duplication, the extraction of essential safety information, and the capability to auto-fill safety case forms, which can be easily submitted to safety databases in E2B or Excel/PDF formats with just one click. Furthermore, it provides automated translation services for abstracts and complete articles into English. DF Literature Monitor is equipped with customizable workflows that promote teamwork and ensure quality control within pharmacovigilance teams. By adopting this solution, organizations can significantly reduce the time and resources spent on literature monitoring by as much as 60% or more, all while maintaining high standards of quality and regulatory compliance. Ultimately, the tool represents a significant advancement in the field of pharmacovigilance, allowing teams to focus on critical analysis rather than manual processes.
Learn more
